dc.contributor.author
Heikkinen, Paula H.
dc.contributor.author
Pulvermüller, Friedemann
dc.contributor.author
Mäkelä, Jyrki P.
dc.contributor.author
Ilmoniemi, Risto J.
dc.contributor.author
Lioumis, Pantelis
dc.contributor.author
Kujala, Teija
dc.contributor.author
Manninen, Riitta-Leena
dc.contributor.author
Ahvenainen, Antti
dc.contributor.author
Klippi, Anu
dc.date.accessioned
2019-07-18T07:41:02Z
dc.date.available
2019-07-18T07:41:02Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/25105
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-2860
dc.description.abstract
Neuromodulation technologies, such as transcranial magnetic stimulation (TMS), are promising tools for neurorehabilitation, aphasia therapy included, but not yet in common clinical use. Combined with behavioral techniques, in particular treatment-efficient Intensive Language-Action Therapy (ILAT, previously CIAT or CILT), TMS could substantially amplify the beneficial effect of such behavioral therapy alone (Thiel et al., 2013; Martin et al., 2014; Mendoza et al., 2016; Kapoor, 2017). In this randomized study of 17 subjects with post-stroke aphasia in the chronic stage, we studied the combined effect of ILAT and 1-Hz placebo-controlled navigated repetitive TMS (rTMS) to the right-hemispheric inferior frontal cortex—that is, to the anterior part of the non-dominant hemisphere's homolog Broca's area (pars triangularis). Patients were randomized to groups A and B. Patients in group A received a 2-week period of rTMS during naming training where they named pictures displayed on the screen once every 10 s, followed by 2 weeks of rTMS and naming combined with ILAT. Patients in group B received the same behavioral therapy but TMS was replaced by sham stimulation. The primary outcome measures for changes in language performance were the Western Aphasia Battery's aphasia quotient AQ; the secondary outcome measures were the Boston naming test (BNT) and the Action naming test (Action BNT, ANT). All subjects completed the study. At baseline, no statistically significant group differences were discovered for age, post-stroke time or diagnosis. ILAT was associated with significant improvement across groups, as documented by both primary and secondary outcome measures. No significant effect of rTMS could be documented. Our results agree with previous results proving ILAT's ability to improve language in patients with chronic aphasia. In contrast with earlier claims, however, a beneficial effect of rTMS in chronic post-stroke aphasia rehabilitation was not detected in this study.
en
dc.format.extent
13 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
chronic aphasia
en
dc.subject
language rehabilitation
en
dc.subject
randomized controlled trial (RCT)
en
dc.subject.ddc
400 Sprache::410 Linguistik::410 Linguistik
dc.subject.ddc
100 Philosophie und Psychologie::150 Psychologie::158 Angewandte Psychologie
dc.title
Combining rTMS with intensive language-action therapy in chronic aphasia: A randomized controlled trial
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
1036
dcterms.bibliographicCitation.doi
10.3389/fnins.2018.01036
dcterms.bibliographicCitation.journaltitle
Frontiers in neuroscience
dcterms.bibliographicCitation.volume
12
dcterms.bibliographicCitation.url
https://doi.org/10.3389/fnins.2018.01036
refubium.affiliation
Philosophie und Geisteswissenschaften
refubium.affiliation.other
Institut für Deutsche und Niederländische Philologie
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.issn
1662-4548
dcterms.isPartOf.eissn
1662-453X
refubium.resourceType.provider
WoS-Alert